ADHD Clinical Trials
Find clinical trials for ADHD. Search for ADHD clinical trials in different cities and states across the United States.
Testing "SupporT for ADHD and Related Treatment" (START) for Families of Children With ADHD
Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Location:
Code:
NCT05796427
Conditions
ADHD
Eligibility Criteria
Sex: All
Age: 6 - 12
Healthy Volunteers: Not accepted
Interventions
SupporT for ADHD and Related Treatment
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
Sponsor:
Children's National Research Institute
Location:
Code:
NCT05099874
Conditions
Sickle Cell Disease
Attention Deficit
Cognitive Deficit in Attention
Eligibility Criteria
Sex: All
Age: 8 - 16
Healthy Volunteers: Not accepted
Interventions
EndeavorRx
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Sponsor:
Oregon Health and Science University
Location:
Code:
NCT06133231
Conditions
Attention Deficit/Hyperactivity Disorder
Emotional Dysfunction
Irritable Mood
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants
Big Feelings: A Study on Children's Emotions in Therapy
Sponsor:
University of Guelph
Location:
Code:
NCT05637320
Conditions
Anxiety Disorders
Depressive Disorder
Mood Disorders
Conduct Disorder
Oppositional Defiant Disorder
Eligibility Criteria
Sex: All
Age: 8 - 15
Healthy Volunteers: Not accepted
Interventions
Modular Approach to Therapy for Children with Anxiety, Depression, Trauma or Conduct Problems
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Sponsor:
Icahn School of Medicine at Mount Sinai
Location:
Code:
NCT03781765
Conditions
ADHD
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 7 - 12
Healthy Volunteers: Not accepted
Interventions
Methylphenidate
Atomoxetine
Enhancing ADHD Driving Performance With Stimulant Medication
Sponsor:
University of Virginia
Location:
Code:
NCT00572026
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 18 - 25
Healthy Volunteers: Not accepted
Interventions
Methylphenidate Transdermal System
Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing
Sponsor:
UCLA
Location:
Code:
NCT06036420
Conditions
ADHD
Eligibility Criteria
Sex: All
Age: 14 - 17
Healthy Volunteers: Not accepted
Interventions
Flashed Light Therapy
Videoconference-delivered Cognitive Behavioral Therapy
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Sponsor:
Weill Medical College of Cornell University
Location:
Code:
NCT00644566
Conditions
ADHD
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Shared Care
What are ADHD clinical trials?
ADHD (Attention Deficit Hyperactivity Disorder) clinical trials are research studies designed to improve understanding of the condition and uncover better treatment options or management therapies for ADHD. As a condition thought to have a strong neurological basis, researchers are keen to understand how treatments can be used to improve symptoms and the management of ADHD.
These clinical trials are vital for improving treatment options for people living with ADHD, including ensuring any new medications, therapies, devices, or lifestyle interventions are safe and effective.
Why ADHD clinical trials are important
ADHD clinical trials are crucial for the research landscape of this condition, helping science to understand ADHD better so that it can be effectively managed and treated safely.
These studies are vital for testing new medications that can calm symptoms, understanding behaviors in those with ADHD, and enhancing the quality of life for people with ADHD. They are also important for diagnosing ADHD and understanding more about the condition so that people can get the right treatment earlier.
Types of clinical trials for ADHD
Clinical trials for ADHD include various types of studies aimed at improving treatment and understanding the disorder. These trials often include randomized controlled trials (RCTs), observational studies, and behavioral intervention trials.
Observational studies
Observational studies are designed to watch and learn from those living with ADHD to better understand how symptoms manifest themselves, identify patterns, and gather insights. This could include monitoring a group of participants or studying previously collected data to establish more outcomes.
Researchers may observe people with ADHD in a medical setting, although real-world environments typically offer better outcomes, particularly for children with ADHD. If designed and carried out properly, researchers can gather valuable data that can be used to inform treatment options or preventative measures.
Treatment trials
Treatment trials are used to test new treatments for ADHD. There are several types of treatment trials available to researchers, depending on the objective or desired outcome. One common type is randomized controlled trials (RCTs), where participants are assigned to either a treatment group or a placebo group to test the effectiveness and safety of medications, such as stimulants or non-stimulants.
Researchers may also use behavioral therapy trials to test new therapies, device trials to test new gadgets and tools for ADHD, or combination treatment trials which test medications and therapies or devices together.
Quality of life trials
In quality of life trials, researchers aim to discover ways to improve the lives of those living with ADHD. They are typically designed as a combination trial, observing participants before testing treatments to see which treatments make their life better. Researchers will seek to help participants manage symptoms and enhance their daily function.
Why participate in a clinical trial for ADHD
There are many reasons why someone might participate in a clinical trial for ADHD, with benefits for both the participant and the wider medical research landscape.
Benefits to participants
For participants, taking part in a clinical trial for ADHD can provide access to new treatments that could improve their symptoms and quality of life. Through this participation, they will also be subject to close monitoring which means better access to medical care they may not have received outside the trial.
Another key benefit is the motivation and wellbeing prospects that come with providing a contribution to medical science which could support future advancements in treatment and others living with the condition.
Risks and considerations
As with any type of clinical trial, ADHD clinical trials also come with risks and considerations. Participants should thoroughly understand the risks and expectations before agreeing to take part in a clinical trial. These could include potential side effects of new drugs or treatments, which can range from mild to severe and may be unknown due to the investigational nature of the therapies.
Additionally, there may be no direct benefit to the individual, as the treatment might not be effective, so it’s important to also consider the time and travel commitment required for the duration of the trial.
Who can participate in ADHD clinical trials?
Depending on the clinical trial requirements and objectives, ADHD trials could be suitable for a number of different people living with the condition. Some trials may have age requirements, for example if they are focusing on treatments for children or adults with ADHD, while other studies could be open to all ages and seek to include participants who are not yet diagnosed.
When researching clinical trials for ADHD, you’ll be able to see the eligibility criteria before you apply. This could include age requirements, sex, diagnosis stage, whether you’ve responded to other treatments, or even people without a diagnosis seeking to prevent ADHD.
Considering volunteering in a clinical trial? Explore our comprehensive guide to learn more about why people choose to volunteer and the impact you can make in advancing medical research. Discover the process of volunteering, what to consider before applying and the potential benefits and risks involved.
What to expect when participating in an ADHD clinical trial
When participating in a clinical trial for ADHD, you can expect to take part in a thorough screening process before the trial begins to assess your eligibility. You will also need to provide informed consent to take part in the trial, ensuring you fully understand the purpose of the trial, its procedures, and any potential risks or benefits.
During the trial, you may be expected to make regular visits to the study site or allow researchers into your home, complete assessments, adhere to treatment plans, and undergo close monitoring, particularly if you are participating in a drug trial. These requirements may differ from trial to trial depending on the objective, but this will be outlined at the beginning of the study so you know what to expect.
How to enroll in an ADHD clinical trial
Enrolling in a clinical trial studying ADHD through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.